About this Event
This is a private, medical practitioner–only discussion.
Aeterna Health is hosting a small, in-person professional discussion focused on the hospital-based delivery of autologous cell therapy for selected knee osteoarthritis patients aged 60–74.
The session will explore:
- Where autologous cell therapy may sit in knee OA management
- Australian regulatory and governance considerations
- Why care setting and hospital-based delivery matter
- Appropriate patient selection and professional positioning
This is not a product presentation.
There will be no outcome claims, no consumer marketing, and no obligation to proceed further.
Aeterna Health operates exclusively within accredited hospital environments and engages with medical practitioners through a compliance-first, governance-led model.
Attendance is limited to support professional discussion.
Event Venue & Nearby Stays
Cohort Innovation Space - Health and Knowledge Precinct., 16 Nexus Way, Southport, Australia
USD 0.00





